documents: FDA-1997-N-0011-0037
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1997-N-0011-0037 | FDA | FDA-1997-N-0011 | Reference 7 - "Transcript of Transmissible Spongiform Encephalopathies Advisory Committee Meeting - October 7, 1997" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030 | Supporting & Related Material | BKG-Background Material | 2010-09-09T04:00:00Z | 2010 | 9 | 2016-01-15T20:40:32Z | 0 | 0 | 0900006480b395f8 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref